{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:05:29Z","timestamp":1790697929986,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010249","name":"Indiana University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Patient Education and Counseling"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.pec.2023.107904","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T11:22:44Z","timestamp":1689592964000},"page":"107904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Patient understanding of pharmacogenomic test results in clinical care"],"prefix":"10.1016","volume":"115","author":[{"given":"Tom A.","family":"Doyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin M.E.","family":"Halverson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler A.","family":"Shugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Skaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pec.2023.107904_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/FPC.0000000000000400","article-title":"Identification of populations likely to benefit from pharmacogenomic testing","volume":"30","author":"Heise","year":"2020","journal-title":"Pharm Genom"},{"issue":"6","key":"10.1016\/j.pec.2023.107904_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5345","article-title":"Projected prevalence of actionable pharmacogenetic variants and level a drugs prescribed among us veterans health administration pharmacy users","volume":"2","author":"Chanfreau-Coffinier","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pec.2023.107904_bib3","unstructured":"IGNITE Network. Implementation Guides. IGNITE. Accessed September 20, 2022. \u3008https:\/\/gmkb.org\/implementation-guides\/\u3009."},{"key":"10.1016\/j.pec.2023.107904_bib4","first-page":"229","article-title":"Updating the landscape of direct-to-consumer pharmacogenomic testing","volume":"Volume 10","author":"Filipski","year":"2017","journal-title":"Pharm Pers Med"},{"issue":"1","key":"10.1016\/j.pec.2023.107904_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cpt.2387","article-title":"Pharmacogenomic clinical decision support: a review, how\u2010to guide, and future vision","volume":"112","author":"Wake","year":"2022","journal-title":"Clin Pharm Ther"},{"issue":"2","key":"10.1016\/j.pec.2023.107904_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jamia\/ocy156","article-title":"Pharmacogenomic clinical decision support design and multi-site process outcomes analysis in the eMERGE network","volume":"26","author":"Herr","year":"2019","journal-title":"J Am Med Inf Assoc JAMIA"},{"issue":"3","key":"10.1016\/j.pec.2023.107904_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/pharmacy8030163","article-title":"Clinical application and educational training for pharmacogenomics","volume":"8","author":"Guy","year":"2020","journal-title":"Pharmacy"},{"issue":"4","key":"10.1016\/j.pec.2023.107904_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1399-0004.2012.01908.x","article-title":"Primary care physicians\u2019 knowledge of and experience with pharmacogenetic testing: Primary care physicians\u2019 and pharmacogenetic testing","volume":"82","author":"Haga","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.pec.2023.107904_bib9","article-title":"Teach-back: a systematic review of implementation and impacts","volume":"15","author":"Talevski","year":"2020"},{"issue":"15","key":"10.1016\/j.pec.2023.107904_bib10","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2217\/pgs-2016-0077","article-title":"Patient experiences with pharmacogenetic testing in a primary care setting","volume":"17","author":"Haga","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"7","key":"10.1016\/j.pec.2023.107904_bib11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/gim.2016.192","article-title":"Participant-perceived understanding and perspectives on pharmacogenomics: the Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time","volume":"19","author":"Olson","year":"2017","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.pec.2023.107904_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2217\/pgs-2019-0006","article-title":"Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory","volume":"20","author":"Haga","year":"2019","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.pec.2023.107904_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2217\/pgs-2017-0191","article-title":"Patient perspectives following pharmacogenomics results disclosure in an integrated health system","volume":"19","author":"Lemke","year":"2018","journal-title":"Pharmacogenomics"},{"issue":"9","key":"10.1016\/j.pec.2023.107904_bib14","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/jpm12091398","article-title":"Development and validation of the minnesota assessment of pharmacogenomic literacy (MAPL)","volume":"12","author":"Allen","year":"2022","journal-title":"J Pers Med"},{"issue":"5","key":"10.1016\/j.pec.2023.107904_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/cpt.2526","article-title":"Clinical pharmacogenetics implementation consortium guideline for CYP2C19 genotype and clopidogrel therapy: 2022 update","volume":"112","author":"Lee","year":"2022","journal-title":"Clin Pharm Ther"},{"issue":"6","key":"10.1016\/j.pec.2023.107904_bib16","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cpt.2015","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2C19 and proton pump inhibitor dosing","volume":"109","author":"Lima","year":"2021","journal-title":"Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.pec.2023.107904_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cpt.597","article-title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update","volume":"102","author":"Hicks","year":"2017","journal-title":"Clin Pharm Ther"},{"issue":"8","key":"10.1016\/j.pec.2023.107904_bib18","first-page":"588","article-title":"Brief questions to identify patients with inadequate health literacy","volume":"36","author":"Chew","year":"2004","journal-title":"Fam Med"},{"key":"10.1016\/j.pec.2023.107904_bib19","series-title":"Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Fourth edition","author":"Corbin","year":"2015"},{"key":"10.1016\/j.pec.2023.107904_bib20","series-title":"Abductive Analysis: Theorizing Qualitative Research","author":"Tavory","year":"2014"},{"issue":"1","key":"10.1016\/j.pec.2023.107904_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0263276414551996","article-title":"Critical Neuroscience and Socially Extended Minds","volume":"32","author":"Slaby","year":"2015","journal-title":"Theory Cult Soc"},{"issue":"18","key":"10.1016\/j.pec.2023.107904_bib22","first-page":"1715","article-title":"Quality of discharge practices and patient understanding at an academic medical center","volume":"173","author":"Horwitz","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.pec.2023.107904_bib23","first-page":"E1035","article-title":"Patient understanding of emergency department discharge instructions: where are knowledge deficits greatest?","volume":"19","author":"Engel","year":"2012","journal-title":"Acad Emerg Med J Soc Acad Emerg Med"},{"issue":"2","key":"10.1016\/j.pec.2023.107904_bib24","first-page":"83","article-title":"Patient understanding of benefits, risks, and alternatives to screening colonoscopy","volume":"45","author":"Schwartz","year":"2013","journal-title":"Fam Med"},{"issue":"5","key":"10.1016\/j.pec.2023.107904_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/15265161.2019.1587031","article-title":"Exploring understanding of \u201cunderstanding\u201d: the paradigm case of biobank consent comprehension","volume":"19","author":"Beskow","year":"2019","journal-title":"Am J Bioeth AJOB"},{"issue":"2","key":"10.1016\/j.pec.2023.107904_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/23294515.2020.1851313","article-title":"Incorporating biobank consent into a healthcare setting: challenges for patient understanding","volume":"12","author":"Kasperbauer","year":"2021","journal-title":"AJOB Empir Bioeth"},{"issue":"5","key":"10.1016\/j.pec.2023.107904_bib27","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s10897-018-0218-8","article-title":"Psychosocial impact of a positive gene result for asymptomatic relatives at risk of hypertrophic cardiomyopathy","volume":"27","author":"Bonner","year":"2018","journal-title":"J Genet Couns"},{"issue":"5","key":"10.1016\/j.pec.2023.107904_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10897-010-9307-z","article-title":"Misunderstandings concerning genetics among patients confronting genetic disease","volume":"19","author":"Klitzman","year":"2010","journal-title":"J Genet Couns"},{"key":"10.1016\/j.pec.2023.107904_bib29","article-title":"Overconfidence in managing health concerns: the dunning\u2013kruger effect and health literacy","author":"Canady","year":"2022","journal-title":"J Clin Psychol Med Settings"},{"issue":"5","key":"10.1016\/j.pec.2023.107904_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/FPC.0000000000000275","article-title":"Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation","volume":"27","author":"Lee","year":"2017","journal-title":"Pharm Genom"},{"issue":"5","key":"10.1016\/j.pec.2023.107904_bib31","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s10897-018-0239-3","article-title":"Parkinson\u2019s disease: patients\u2019 knowledge, attitudes, and interest in genetic counseling","volume":"27","author":"Maloney","year":"2018","journal-title":"J Genet Couns"},{"issue":"1","key":"10.1016\/j.pec.2023.107904_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13142-012-0149-0","article-title":"Translational genomic research: protocol development and initial outcomes following SNP testing for colon cancer risk","volume":"3","author":"Nusbaum","year":"2013","journal-title":"Transl Behav Med"},{"issue":"6","key":"10.1016\/j.pec.2023.107904_bib33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/hex.12406","article-title":"Public preferences for communicating personal genomic risk information: a focus group study","volume":"19","author":"Smit","year":"2016","journal-title":"Health Expect"},{"issue":"1","key":"10.1016\/j.pec.2023.107904_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1049732319858325","article-title":"Patient and health care provider needs and preferences in understanding pharmacogenomic and genomic testing: a meta-data analysis","volume":"30","author":"Veilleux","year":"2020","journal-title":"Qual Health Res"},{"issue":"1","key":"10.1016\/j.pec.2023.107904_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-6920-7-17","article-title":"Communicating genetic information: a difficult challenge for future pediatricians","volume":"7","author":"Rosas-Blum","year":"2007","journal-title":"BMC Med Educ"},{"issue":"12","key":"10.1016\/j.pec.2023.107904_bib36","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2217\/pgs.12.113","article-title":"The current and future state of pharmacogenomics medical education in the USA","volume":"13","author":"Nickola","year":"2012","journal-title":"Pharmacogenomics"},{"issue":"10","key":"10.1016\/j.pec.2023.107904_bib37","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2217\/pgs-2017-0038","article-title":"Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experience","volume":"18","author":"Rohrer Vitek","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"9","key":"10.1016\/j.pec.2023.107904_bib38","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2217\/pgs.10.122","article-title":"Pharmacogenomics instruction in US and Canadian medical schools: implications for personalized medicine","volume":"11","author":"Green","year":"2010","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.pec.2023.107904_bib39","first-page":"284","article-title":"Use and effectiveness of the teach-back method in patient education and health outcomes","volume":"36","author":"Yen","year":"2019","journal-title":"Fed Pr Health Care Prof VA DoD PHS"},{"issue":"2","key":"10.1016\/j.pec.2023.107904_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0250-474X.103857","article-title":"Development and evaluation of patient information leaflets (PIL) usefulness","volume":"74","author":"Adepu","year":"2012","journal-title":"Indian J Pharm Sci"},{"issue":"6","key":"10.1016\/j.pec.2023.107904_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/13625187.2017.1412425","article-title":"Impact of a pharmacist-provided information booklet on knowledge and attitudes towards oral contraception among Jordanian women: an interventional study","volume":"22","author":"Akour","year":"2017","journal-title":"Eur J Contracept Reprod Health Care J Eur Soc Contracept"},{"issue":"1","key":"10.1016\/j.pec.2023.107904_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/keg032","article-title":"The development and evaluation of a drug information leaflet for patients with rheumatoid arthritis","volume":"42","author":"Hill","year":"2003","journal-title":"Rheuma Oxf Engl"},{"issue":"2","key":"10.1016\/j.pec.2023.107904_bib43","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1188\/16.CJON.E28-E33","article-title":"Written information improves patient knowledge about implanted ports","volume":"20","author":"Piredda","year":"2016","journal-title":"Clin J Oncol Nurs"},{"issue":"4","key":"10.1016\/j.pec.2023.107904_bib44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2125.2007.02968.x","article-title":"Impact of Vietnamese written and verbal medicine information on Vietnamese-speaking Australians\u2019 knowledge and satisfaction","volume":"64","author":"Mai","year":"2007","journal-title":"Br J Clin Pharm"},{"key":"10.1016\/j.pec.2023.107904_bib45","first-page":"1913","article-title":"Barriers, facilitators, and solutions to optimal patient portal and personal health record use: a systematic review of the literature","volume":"2017","author":"Zhao","year":"2017","journal-title":"AMIA Annu Symp Proc AMIA Symp"},{"issue":"3","key":"10.1016\/j.pec.2023.107904_bib46","first-page":"197","article-title":"Survey of US public attitudes toward pharmacogenetic testing","volume":"12","author":"Haga","year":"2012","journal-title":"Pharm J"},{"issue":"3","key":"10.1016\/j.pec.2023.107904_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/gtmb.2011.0118","article-title":"Public perspectives about pharmacogenetic testing and managing ancillary findings","volume":"16","author":"Haga","year":"2012","journal-title":"Genet Test Mol Biomark"},{"issue":"1","key":"10.1016\/j.pec.2023.107904_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/14622416.7.1.49","article-title":"Patients\u2019 and physicians\u2019 perspectives on pharmacogenetic testing","volume":"7","author":"Rogausch","year":"2006","journal-title":"Pharmacogenomics"}],"container-title":["Patient Education and Counseling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738399123002847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738399123002847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:48:38Z","timestamp":1760035718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738399123002847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":48,"alternative-id":["S0738399123002847"],"URL":"https:\/\/doi.org\/10.1016\/j.pec.2023.107904","relation":{},"ISSN":["0738-3991"],"issn-type":[{"value":"0738-3991","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient understanding of pharmacogenomic test results in clinical care","name":"articletitle","label":"Article Title"},{"value":"Patient Education and Counseling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pec.2023.107904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107904"}}